Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03637803
Title MRx0518 and Pembrolizumab Combination Study
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors 4DPharma PLC
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.